Actividad Investigadora
Contratos Miguel Servet Tipo II
Datos básicos
- Código del Financiador:
- CPII21/00004
- Año Inicial:
- 2022
- Año final:
- 2025
Objetivos del proyecto
Contrato Miguel Servet Tipo II de Raquel López Mejías
Documentos
- No hay documentos
Participantes
Unidades de investigación
Financiadores
INSTITUTO DE SALUD CARLOS III.
Resultados del Proyecto
CHARACTERIZING THE PRE-DISEASE STATE OF PSORIATIC ARTHRITIS: CXCL10 LEVELS ARE ASSOCIATED WITH SUBCLINICAL SYNOVITIS IN PATIENTS WITH PSORIASIS
Meeting Abstract. 10.1136/annrheumdis-2023-eular.5466. 2023
ENDOTHELIN-1 AS A POTENTIAL CANDIDATE TO SHED LIGHT ON THE CHALLENGE OF INTERSTITIAL LUNG DISEASE DIAGNOSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
Meeting Abstract. 10.1136/annrheumdis-2023-eular.2007. 2023
Increase of Serum Endothelin-1 Levels in Patients with Interstitial Lung Disease Associated with Autoimmune Diseases
Meeting Abstract. 2022
MUCOSAL IMMUNE DEFENCE POLYMORPHISMS: RELEVANT PLAYERS IN IGA VASCULITIS?
Meeting Abstract. 10.1136/annrheumdis-2023-eular.73. 2023
Nuclear Factor of Activated T Cells Cytoplasmic 1 as a Potential Biomarker of Increased Cardiovascular Risk in Patients with Early Rheumatoid Arthritis
Meeting Abstract. 2022
PLEUROPARENCHYMAL FIBROELASTOSIS: A SPECIAL CLINICAL SITUATION IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASES. DESCRIPTIVE STUDY FROM A REFERRAL CENTRE
Meeting Abstract. 10.1136/annrheumdis-2023-eular.1387. 2023